Journal of Immunology
Adam Kennedy link to other pubmed listings for this student
2006 Nov 15;177(10):7435-43
Thrice-weekly low-dose rituximab decreases CD20 loss via shaving and promotes enhanced targeting in chronic lymphocytic leukemia.
Adam Kennedy link to other pubmed listings for this student
2006 Feb 15;176(4):2600-9
The shaving reaction: rituximab/CD20 complexes are removed from mantle cell lymphoma and chronic lymphocytic leukemia cells by THP-1 monocytes.
Adam Kennedy link to other pubmed listings for this student
2004 Mar 1;172(5):3280-8
Rituximab infusion promotes rapid complement depletion and acute CD20 loss in chronic lymphocytic leukemia.
Adam Kennedy link to other pubmed listings for this student
2003 Apr 1;170(7):3671-8
B cell complement receptor 2 transfer reaction.
Emily Whipple link to other pubmed listings for this student
2004 Aug 15;173(4):2297-306
Analyses of the in vivo trafficking of stoichiometric doses of an anti-complement receptor 1/2 monoclonal antibody infused intravenously in mice.